49
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation

ORCID Icon, ORCID Icon, , , ORCID Icon, & show all
Pages 2847-2868 | Received 07 Mar 2024, Accepted 25 Jun 2024, Published online: 09 Jul 2024

References

  • Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770.
  • Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol. 2020;35(3):380–389.
  • Shah SC, Itzkowitz SH. Colorectal Cancer in Inflammatory Bowel Disease: mechanisms and Management. Gastroenterology. 2022;162(3):715–730e713.
  • Paik J. Ozanimod: a Review in Ulcerative Colitis. Drugs. 2022;82(12):1303–1313.
  • Hanzel J, Hulshoff MS, Grootjans J, D’Haens G. Emerging therapies for ulcerative colitis. Expert Rev Clin Immunol. 2022;18(5):513–524.
  • Liu Y, Li BG, Su YH, et al. Potential activity of Traditional Chinese Medicine against Ulcerative colitis: a review. J Ethnopharmacol. 2022;289:115084.
  • Zhu C, Li K, Peng XX, et al. Berberine a traditional Chinese drug repurposing: its actions in inflammation-associated ulcerative colitis and cancer therapy. Front Immunol. 2022;13:1083788.
  • Wu J, Luo Y, Shen Y, et al. Integrated Metabonomics and Network Pharmacology to Reveal the Action Mechanism Effect of Shaoyao Decoction on Ulcerative Colitis. Drug Des Devel Ther. 2022;16:3739–3776.
  • Luo Y, Wu J, Liu Y, et al. Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS. Drug Des Devel Ther. 2022;16:4343–4364.
  • Lu QK, Fu YF, Li H. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders. Pharmacol Rep. 2022;74(2):297–309.
  • Khoshandam A, Imenshahidi M, Hosseinzadeh H. Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: a comprehensive review. Phytother Res. 2022;36(11):4063–4079.
  • Tang X, Yang M, Gu Y, Jiang L, Du Y, Liu J. Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis. Drug Des Devel Ther. 2021;15:4105–4123.
  • Cooper SF, Mockle JA, Beliveau J. Alkaloids of Coptis groenlandica. Planta Med. 1970;19(1):23–29.
  • Xu Y, Huang J, Fan Y, et al. Macrophage-Targeted Berberine-Loaded beta-Glucan Nanoparticles Enhance the Treatment of Ulcerative Colitis. Int J Nanomed. 2022;17:5303–5314.
  • Dong YL, Fan H, Zhang Z, et al. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway. Int J Biol Sci. 2022;18(4):1381–1397.
  • Li H, Fan C, Lu HM, et al. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions. Acta Pharmacol Sin B. 2020;10(3):447–461.
  • Zhou Y, Yang S, Guo J, et al. In Vivo Imaging of Hypoxia Associated with Inflammatory Bowel Disease by a Cytoplasmic Protein-Powered Fluorescence Cascade Amplifier. Anal Chem. 2020;92(8):5787–5794.
  • Dai W, Long L, Wang X, Li S, Xu H. Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease. Chin Med. 2022;17(1):53.
  • Dvornikova KA, Platonova ON, Bystrova EY. Hypoxia and Intestinal Inflammation: common Molecular Mechanisms and Signaling Pathways. Int J Mol Sci. 2023;24(3).
  • Vidal-Limon A, Aguilar-Toala JE, Liceaga AM. Integration of Molecular Docking Analysis and Molecular Dynamics Simulations for Studying Food Proteins and Bioactive Peptides. J Agric Food Chem. 2022;70(4):934–943.
  • Gallo K, Goede A, Preissner R, Gohlke BO. SuperPred 3.0: drug classification and target prediction-A machine learning approach. Nucleic Acids Res. 2022;50(W1):W726–W731.
  • Liu X, Ouyang S, Yu B, et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 2010;38:W609–W614.
  • Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357–W364.
  • Fang S, Dong L, Liu L, et al. HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 2021;49(D1):D1197–D1206.
  • Xu HY, Zhang YQ, Liu ZM, et al. ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2019;47(D1).
  • Kuhn M, Szklarczyk D, Franceschini A, et al. STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res. 2010;38(Database issue):D552–556.
  • Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.
  • Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–D1082.
  • UniProt C. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–D489.
  • Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–D612.
  • Goodsell DS, Zardecki C, Di Costanzo L, et al. RCSB Protein Data Bank: enabling biomedical research and drug discovery. Protein Sci. 2020;29(1):52–65.
  • O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33.
  • Zhang Y, Sanner MF. AutoDock CrankPep: combining folding and docking to predict protein-peptide complexes. Bioinformatics. 2019;35(24):5121–5127.
  • Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8(18):1555–1572.
  • Hsin KY, Ghosh S, Kitano H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS One. 2013;8(12).
  • Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238–249.
  • Bell CJ, Gall DG, Wallace JL. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol. 1995;268(4):G622–630.
  • Wu D, Zhang Y, Zou B, Lu Y, Cao H. Shaoyao decoction alleviates TNBS-induced ulcerative colitis by decreasing inflammation and balancing the homeostasis of Th17/Treg cells. BMC Complement Med Ther. 2023;23(1):424.
  • Narita T, Yin S, Gelin CF, et al. Identification of a novel small molecule HIF-1alpha translation inhibitor. Clin Cancer Res. 2009;15(19):6128–6136.
  • Sun L, Nie X, Lu W, et al. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis. AAPS Pharm Sci Tech. 2022;23(6):179.
  • Orazi A, Arber DA. Pathology of the spleen: introduction. Semin Diagn Pathol. 2021;38(2):111.
  • Xutian S, Zhang J, Louise W. New exploration and understanding of traditional Chinese medicine. Am J Chin Med. 2009;37(3):411–426.
  • Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol. 2014;12(5):756–764.
  • Xu L, Zhang Y, Xue X, et al. A Phase I Trial of Berberine in Chinese with Ulcerative Colitis. Cancer Prev Res (Phila). 2020;13(1):117–126.
  • Xu X, Li W, Yu Z, et al. Berberine Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis and Inhibits the Secretion of Gut Lysozyme via Promoting Autophagy. Metabolites. 2022;12(8).
  • Izadparast F, Riahi-Zajani B, Yarmohammadi F, Hayes AW, Karimi G. Protective effect of berberine against LPS-induced injury in the intestine: a review. Cell Cycle. 2022;21(22):2365–2378.
  • Escudero-Hernandez C, van Beelen Granlund A, Bruland T, et al. Transcriptomic Profiling of Collagenous Colitis Identifies Hallmarks of Nondestructive Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2021;12(2):665–687.
  • Chen Y, Yan W, Chen Y, et al. SLC6A14 facilitates epithelial cell ferroptosis via the C/EBPbeta-PAK6 axis in ulcerative colitis. Cell Mol Life Sci. 2022;79(11):563.
  • Brown E, Rowan C, Strowitzki MJ, et al. Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1alpha response in ulcerative colitis patients. FASEB J. 2020;34(3):3732–3742.
  • Yuan Z, Pan Y, Leng T, et al. Progress and Prospects of Research Ideas and Methods in the Network Pharmacology of Traditional Chinese Medicine. J Pharm Pharm Sci. 2022;25:218–226.
  • Li H, Wang Y, Shao S, et al. Rabdosia serra alleviates dextran sulfate sodium salt-induced colitis in mice through anti-inflammation, regulating Th17/Treg balance, maintaining intestinal barrier integrity, and modulating gut microbiota. J Pharm Anal. 2022;12(6):824–838.
  • Tam JSY, Coller JK, Hughes PA, Prestidge CA, Bowen JM. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation. Indian J Gastroenterol. 2021;40(1):5–21.
  • Yousefi-Manesh H, Dejban P, Mumtaz F, et al. Risperidone attenuates acetic acid-induced colitis in rats through inhibition of TLR4/NF-kB signaling pathway. Immunopharm Immunot. 2020;42(5):464–472.
  • Rashidian A, Muhammadnejad A, Dehpour AR, et al. Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology. 2016;24(2–3).
  • Yin J, Ren Y, Yang K, et al. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease. Cell Biol Int. 2022;46(1):46–51.
  • Li MY, Luo HJ, Wu X, et al. Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways. Front Pharmacol. 2020;10.
  • Zhuang H, Lv Q, Zhong C, et al. Tiliroside Ameliorates Ulcerative Colitis by Restoring the M1/M2 Macrophage Balance via the HIF-1alpha/glycolysis Pathway. Front Immunol. 2021;12:649463.